Subscribe To
Context therapeutics announces manufacturing agreement with lonza for bispecific antibody targeting claudin 6 positive cancers
Context Therapeutics (NASDAQ:CNTX) Inc said it will be collaborating with Lonza, a global development and manufacturing partner to the pharma, biotech...
January 9, 2023, 9:03 am
Fda accepts astrazeneca (azn), sanofi's rsv antibody bla
The FDA's decision on AstraZeneca (AZN)/Sanofi's (SNY) regulatory filing, seeking approval for using their RSV ...
January 6, 2023, 3:03 pm
Abbvie briefly breaks out after tapping immunome in $30 million cancer deal
AbbVie stock briefly broke out Friday after the company signed a $30 million deal with small biotech Immunome in ...
January 6, 2023, 1:45 pm
Abbvie and immunome partner to find new cancer treatments
Immunome and AbbVie announced a worldwide collaboration and option agreement to discover up to 10 new antibody-target pairs for treating three specifi...
January 6, 2023, 11:17 am
Macrogenics to present at the 41st annual j.p. morgan healthcare conference
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializ...
January 4, 2023, 10:50 pm
Macrogenics to present at the 41st annual j.p. morgan healthcare conference
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercial...
January 4, 2023, 5:50 pm
Tg therapeutics announces fda approval of briumvi™ (ublituximab-xiiy)
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms ...
December 28, 2022, 6:48 pm
Immunogen announces webcast of presentation and q&a at the 41st annual j.p. morgan healthcare conference
WALTHAM, Mass.--( BUSINESS WIRE )--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatmen...
December 27, 2022, 4:30 pm
Bio-rad (bio) core diagnostic sales grow amid supply challenges
Bio-Rad's (BIO) underlying Life Science currency-neutral core revenue growth is primarily driven by Western loading, qPCR, process media and ...
December 23, 2022, 11:17 am
Roche gets full fda approval for covid-19 treatment
Roche Holding AG ROG, -0.50% said late Wednesday that the Food and Drug Administration formally approved its monoclonal ...
December 22, 2022, 9:49 am
Avidity biosciences: unique antibody-oligonucleotide conjugate technology
Avidity Biosciences' stock was up 55% last week after releasing preliminary data from a Phase 1/ 2 study of its antibody-oligonucleotide technology ca...
December 22, 2022, 5:22 am
Roche's phase 3 data show lymphoma treatment can reduce disease risks
Roche Holding AG presented new data from a Phase 3 study showing that its Polivy antibody-drug can significantly reduce the risk of disease deteriorat...
December 12, 2022, 2:24 am
Vincerx pharma presents preclinical data on vip943 in acute myeloid leukemia models at the 64th american society of hematology annual meeting 2022
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conj...
December 11, 2022, 3:05 pm
Biopharma co.’s shares triple in value on us$5b license deal
Source: Streetwise Reports (12/7/22) Summit Therapeutics Inc. shares traded 194% higher yesterday after the company reported it entered into an in-lic...
December 8, 2022, 1:30 pm
Prometheus biosciences soars as new data indicates therapeutic candidate holds promise for bowel disease
Prometheus Biosciences Inc shares have rocketed more than 170% on positive results for its therapeutic candidate PRA023 in both its ARTEMIS-UC Phase 2...
December 7, 2022, 12:07 pm
Ibio announces pricing of $3.5 million underwritten public offering
BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision ...
December 7, 2022, 4:27 am
Is now the time omniab? 5 insider purchase and 2 bullish initiations propel shares almost 100% higher
It has been a rough start for antibody discovery biotech OmniAb (US:OABI) since listing via a SPAC merg...
December 5, 2022, 10:10 pm
Johnson & johnson: alzheimer's disease pipeline could dominate
Johnson & Johnson selected a vaccine to take to Phase 3. Another rival amyloid beta antibody could appe...
December 5, 2022, 4:56 pm
Ibio announces ceo departure
BRYAN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision ...
December 2, 2022, 9:30 pm
Valneva (valn) up on 6-month lyme disease jab persistence data
Persistence data from a mid-stage study showed that Valneva's (VALN) Lyme disease vaccine elicited antibody ...
December 2, 2022, 12:02 pm